• image

    “Look at the stars
    and not at your feet”
    S. Hawking

    Events

    Stay informed about our latest events:


    June 21 2018

    Current Veterinary Practices (CCVP)

    GST organizes the Conference on Current Veterinary Practices (CCVP) together with two other pharmaceutical companies Eickemeyer and Orthopaedics.

    The CCVP aims at bringing equine veterinarians together to discuss the latest insights in veterinary surgery, medical imaging, drug treatments and horse care. It is  an interactive and practical forum in which equine veterinarians can debate emerging new clinical insights as well as practical experiences with participants and presenters in different areas of expertise.

    We already organized 6 conferences in Belgium and the Nederlands and the 7th CCVP will be held on October 5th 2018.

    For more information on the CCVP, to download the proceedings of previous conferences or to register for the next conference please visit www.ccvp.eu.

    News

    Read our press and magazine articles:


    20 november 2019

    Johan Cardoen joins GST’s board of directors


    Press release: Global Stem cell Technology (GST) NV, a front-runner in the field of veterinary stem cell therapy, announces that Johan Cardoen joins the board of directors.

    09 april 2019

    First-ever registered stem cell-based veterinary medicine!


    Press Release: Boehringer Ingelheim launches Arti-Cell® Forte in Europe for the ‘reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses’.

    11 december 2018

    Boehringer Ingelheim and GST announce collaboration


    Press Release: Boehringer Ingelheim launches Arti-Cell® Forte in Europe for the ‘reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses’.

    28 november 2018

    GST is globally ranked within the top 10 start-ups in animal health


    GST is proud to be ranked within the top 10 start-ups in the latest report “disruptors and innovators 2018” which showcases the leading start-up companies in the animal health sector.

    11 september 2018

    Wereldprimeur voor biotechpionier uit Evergem


    Op 21 juni 2018 gaf het Europese Geneesmiddelenagentschap groen licht voor Arti-Cell Forte, het eerste diergeneeskundig product op basis van stamcellen ter wereld. Het werd ontwikkeld door het Evergemse biotechbedrijf GST, onderdeel van Anacura. " We hebben nog zes medicijnen in de pijplijn, zowel voor paarden als voor honden", vertelt oprichter Jan Spaas.

    22 juni 2018

    First stem cell-based veterinary medicine recommended for marketing authorisation


    Arti-Cell Forte is indicated in horses with mild to moderate lameness due to joint inflammation